Skip to main content
Fig. 5 | Orphanet Journal of Rare Diseases

Fig. 5

From: Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis

Fig. 5

The efficacy of Methotrexate to treat JIA-related uveitis. To determine the efficacy of Methotrexate, we systematically reviewed 8 studies consisted of 632 patients and could show a pooled response rate of40.0% (95%CI: 36.0% to 44.2) to Methotrexate. The statistical heterogeneity was also significant with an I2 of 91.314% (P < 0.001). There was also a significant publication bias (P = 0.016)

Back to article page